Envestnet Asset Management Inc Immunovant, Inc. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$25.1 - $31.61 $143,095 - $180,208
-5,701 Reduced 34.55%
10,799 $285,000
Q1 2024

May 13, 2024
BUY
$30.27 - $43.79 $66,836 - $96,688
2,208 Added 15.45%
16,500 $533,000
Q4 2023

Feb 13, 2024
SELL
$31.31 - $44.19 $447,545 - $631,651
-14,294 Reduced 50.0%
14,292 $602,000
Q3 2023

Nov 13, 2023
BUY
$18.55 - $39.96 $530,270 - $1.14 Million
28,586 New
28,586 $1.1 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email